New Key Statistics Module, Z-Score and F-Score
SZSE:300702 Key Ratios
Market Cap ¥ M | 6,301.87 |
Enterprise Value ¥ M | 7,634.57 |
P/E(ttm) | -- |
PE Ratio without NRI | 73.92 |
Forward PE Ratio | -- |
Price/Book | 1.79 |
Price/Sales | 2.54 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 2,447.00 |
EPS (TTM) ¥ | -0.25 |
Beneish M-Score | -2.21 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -3.90 |
y-y EBITDA Growth Rate % | -142.40 |
EV-to-EBIT | -268.16 |
EV-to-EBITDA | -268.16 |
PEG | -- |
Shares Outstanding M | 347.98 |
Net Margin (%) | -3.63 |
Operating Margin % | 9.94 |
Pre-tax Margin (%) | -3.03 |
Quick Ratio | 0.39 |
Current Ratio | 1.16 |
ROA % (ttm) | -1.40 |
ROE % (ttm) | -2.49 |
ROIC % (ttm) | 6.14 |
Dividend Yield % | -- |
Altman Z-Score | 2.17 |
SZSE:300702 Number of Guru Trades
SZSE:300702 Volume of Guru Trades
Gurus Latest Trades with SZSE:300702
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300702 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Tianyu Pharmaceutical Co Ltd Insider Transactions
No Available Data